Therefore, TGF-β-dependent fine-tuning of 4-1BB signaling contributes to “regulatory” CD73+CD8+ T cell responses via two different aspects: (i) the signal intensity of the STAT3 pathway and (ii) the levels of IFN-γ and IL-2 production in the tumor. This evidence concerns the gene TGFB1 and neoplasm.